Releases
Found 35204 articles
Halper Sadeh Launches Investigation into Acadia Healthcare Leadership
Investors in Acadia Healthcare Company are under scrutiny as New York-based law firm Halper Sadeh LLC probes potential breaches of fiduciary duty by the company’s officers and directors. The investigation centers on whether corporate leadership failed to uphold their obligations to shareholders, potentially impacting the firm's long-term governance and fiscal integrity.
Halper Sadeh Launches Investigation Into TransMedics Group Governance
The New York-based law firm Halper Sadeh LLC has initiated an investigation into potential breaches of fiduciary duty by officers and directors at TransMedics Group, Inc. The probe centers on whether company leadership failed in their obligations to shareholders, potentially impacting the long-term value and governance standards of the NASDAQ-listed firm.
Halper Sadeh Launches Investigation Into MongoDB Leadership
Investors holding MongoDB shares now face questions regarding potential breaches of fiduciary duty by the company’s officers and directors. New York-based law firm Halper Sadeh LLC has initiated an investigation into the firm’s governance, signaling a possible legal challenge over corporate oversight and management practices.
Halper Sadeh Launches Investigation Into Sana Biotechnology Governance
The New York-based law firm Halper Sadeh LLC has initiated an investigation into whether officers and directors at Sana Biotechnology, Inc. breached their fiduciary duties to shareholders. The inquiry focuses on potential failures in corporate oversight, prompting the firm to solicit input from current long-term investors regarding the company's governance practices.
Halper Sadeh Launches Inquiry into Perpetua Resources Governance
The New York-based law firm Halper Sadeh LLC has opened an investigation into potential breaches of fiduciary duty by officers and directors at Perpetua Resources Corp. The inquiry focuses on whether current leadership failed shareholders, potentially opening the door for litigation aimed at governance reforms and financial recovery.
Halper Sadeh Launches Inquiry into BellRing Brands Governance
The New York-based law firm Halper Sadeh LLC has initiated an investigation into potential breaches of fiduciary duty by officers and directors at BellRing Brands, Inc. Legal representatives are currently evaluating whether corporate leadership failed to uphold their obligations to the company’s long-term shareholders.
Halper Sadeh Launches Investigation Into Skyworks Solutions Leadership
The New York-based law firm Halper Sadeh LLC has initiated an investigation into potential breaches of fiduciary duty by officers and directors at Skyworks Solutions, Inc. The probe centers on whether company leadership failed their obligations to NASDAQ-listed shareholders, potentially triggering a push for governance reforms and financial recovery.
Halper Sadeh Launches Investigation into Scotts Miracle-Gro Leadership
Investors in The Scotts Miracle-Gro Company face a potential legal reckoning as Halper Sadeh LLC probes whether company leadership violated their fiduciary responsibilities. The New York-based law firm is currently evaluating the conduct of officers and directors, offering long-term shareholders a path to pursue corporate governance reforms and financial recovery.
Humana Inc. Faces Shareholder Rights Investigation
The New York-based law firm Halper Sadeh LLC has launched an investigation into Humana Inc., focusing on whether the company’s officers and directors breached their fiduciary duties to shareholders. The firm is currently evaluating potential legal actions on behalf of long-term investors holding stock in the healthcare provider.
Halper Sadeh Launches Investigation Into Lululemon Leadership
Investors holding Lululemon Athletica Inc. shares face a potential legal reckoning as New York-based firm Halper Sadeh LLC probes whether company officers and directors failed in their fiduciary responsibilities. The investigation targets the internal governance of the NASDAQ-listed retailer, potentially opening a path for shareholders to demand systemic corporate reforms.
EQT Completes Share Buyback Program
Stockholm-based investment firm EQT AB has concluded its latest share repurchase initiative, acquiring a total of 4,368,899 ordinary shares. The program, which began on July 20, 2026, saw the company deploy over 1.44 billion Swedish krona to stabilize its capital structure by the market close on September 4.
Investors Face October Deadline in York Space Systems Fraud Suit
Investors who suffered financial losses from York Space Systems, Inc. securities now have until October 30, 2026, to move the court to serve as lead plaintiff. The class action lawsuit, brought by Glancy Prongay Wolke & Rotter LLP, alleges the company misled stakeholders regarding the functionality of its satellite software.
Halper Sadeh Launches Investigation Into Beazer Homes Sale
Investors in Beazer Homes USA are facing a potential conflict as the company moves toward a $33.50 per share cash buyout by Dream Finders Homes. New York-based law firm Halper Sadeh LLC has initiated an inquiry into whether the deal shortchanges shareholders or violates federal securities regulations.
Simply Good Foods Investors Face October Deadline in Fraud Lawsuit
Investors who incurred financial losses holding Simply Good Foods Company stock between October 24, 2024, and April 8, 2026, have until October 13, 2026, to seek lead plaintiff status in a pending class action lawsuit filed by the Law Offices of Howard G. Smith.
Navigating Insurance Choices in a Growing Goodyear
Selecting an insurance agent in a rapidly expanding community like Goodyear requires more than a simple price comparison. Edward Vasquez, an Allstate agency owner, argues that the right choice hinges on finding a local professional who prioritizes personalized guidance over standardized, online-only policies.
Interventional Ophthalmology Shifts Eye Care Focus to Early Detection
In Racine, Wisconsin, a shift toward interventional ophthalmology is redefining how doctors approach vision health. By prioritizing early screening and proactive treatment over reactive surgery, specialists Dr. I. Paul Singh and Dr. R. Krishna Sanka are aiming to halt ocular disease before it disrupts a patient’s daily life.
GPGI Shareholders Urged to Join Securities Fraud Class Action
Investors who incurred financial losses holding GPGI, Inc. stock between November 3, 2025, and May 6, 2026, face a critical deadline to participate in a securities fraud class action. The law firm Glancy Prongay Wolke & Rotter LLP is currently seeking lead plaintiffs ahead of the September 14, 2026, court filing cut-off.
Innventure Faces Class Action Lawsuit After Data Center Deal Collapses
Investors who suffered significant losses in Innventure, Inc. have until October 27, 2026, to join a class action lawsuit following a 74% stock price decline. The litigation centers on allegations that the company misled shareholders regarding a purported 300MW AI data center project in Ontario, Canada, that never materialized.
Aardvark Therapeutics Faces Securities Fraud Lawsuit Over Drug Safety
Investors who bought Aardvark Therapeutics stock between February 2025 and May 2026 are facing mounting losses following a securities class action lawsuit. The complaint alleges the biopharmaceutical firm misled shareholders regarding the safety profile of its lead drug candidate, ARD-101, which is intended to treat hyperphagia in Prader-Willi Syndrome.
Hims & Hers Health Investors File Class Action After FTC Complaint
A federal complaint filed by the FTC, alongside regulators in Utah and Los Angeles, has triggered a securities class action against Hims & Hers Health. The litigation follows a July 29, 2026, stock crash that wiped nearly $1 billion from the company's market value after allegations of deceptive data practices surfaced.
DNOW Investors Face October Deadline in Merger-Related Class Action
Investors who held DNOW Inc. common stock as of August 5, 2025, face an October 2, 2026, deadline to seek lead plaintiff status in a federal securities class action. The lawsuit centers on allegations that management downplayed critical software integration failures during the company's acquisition of MRC Global Inc.
Pentair Investors Face Class Action Over Alleged Inventory Misconduct
A securities fraud class action against Pentair plc has expanded, drawing in investors who purchased stock between March 11, 2025, and July 14, 2026. The lawsuit claims executives masked severe inventory issues within the company’s Pool segment, artificially inflating financial metrics before a sudden, sharp market correction.
Pentair Investors Face October Deadline in Securities Fraud Class Action
Investors who incurred significant losses in Pentair plc between March 11 and July 14, 2026, have until October 2 to apply as lead plaintiffs in a pending securities fraud lawsuit. The Law Offices of Howard G. Smith is currently organizing the class action against the company regarding alleged misleading disclosures.
UWM Holdings Faces Class Action Lawsuit After $603 Million Hedge Loss
A 34% single-day share price collapse on August 6, 2026, has triggered a securities class action lawsuit against UWM Holdings Corporation. The litigation centers on the company’s failed acquisition of Two Harbors Investment Corp., which left the mortgage lender saddled with massive, undisclosed hedging losses and a dilution plan for shareholders.
HDFC Bank Faces Securities Fraud Lawsuit Over Alleged Deposit Scheme
Investors in HDFC Bank are facing a potential class action lawsuit after allegations emerged that senior leadership orchestrated a scheme to secure state deposits through disguised payments. The complaint centers on claims that the bank funneled millions in marketing funds to bypass interest rate regulations set by the Reserve Bank of India.
Alibaba Faces Securities Class Action Over Alleged Military Ties
Investors who held Alibaba Group Holding Limited shares between June 2025 and June 2026 are being urged to contact Hagens Berman Sobol Shapiro LLP. A securities class action lawsuit, Wistisen v. Alibaba Group, alleges the company concealed critical regulatory ties and engaged in fraudulent AI distillation practices.
Investors Target PROCEPT BioRobotics Over Alleged Sales Inflation
A securities class action lawsuit has been filed against PROCEPT BioRobotics, accusing the company of artificially inflating revenues through aggressive bulk-discount programs. Shareholders who acquired common stock between February 28, 2024, and February 25, 2026, face a September 22, 2026, deadline to seek lead plaintiff status in the ongoing litigation.
Regeneron Faces Class Action Lawsuit Over Failed Melanoma Drug Trial
Investors have until September 14, 2026, to join a class action lawsuit against Regeneron Pharmaceuticals following a failed Phase 3 clinical trial. The litigation centers on allegations that the company misled shareholders regarding the viability of a combination therapy for metastatic melanoma, resulting in an $11 billion market cap decline.
Capricor Therapeutics Faces Extended FDA Review Amid Securities Lawsuit
Investors in Capricor Therapeutics have until September 28, 2026, to seek lead plaintiff status in a pending class action lawsuit. This legal challenge follows an FDA decision to push back the target action date for the company's Duchenne muscular dystrophy therapy, deramiocel, to November 22, 2026.
Investors File Class Action Against Cogent Communications Over Backlog Claims
A securities class action lawsuit has been filed against Cogent Communications Holdings, alleging the company misled shareholders regarding its optical wavelength backlog. The litigation claims that management touted these figures as growth indicators while failing to disclose that many orders were unlikely to ever convert into actual revenue.